Control of the human osteopontin promoter by ERRα in colorectal cancer

American Journal of Pathology

Volumn 183, Issue 1, 2013, Pages 266-276

  Boudjadi, Salah ^a   Bernatchez, Gérald ^a   Beaulieu, Jean François ^a   Carrier, Julie C ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RELATED RECEPTOR ALPHA; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

AGED; CASE-CONTROL STUDIES; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HT29 CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOPONTIN; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84879403434     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.03.021     Document Type: Article

References (56)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. M.D. McKee, C.E. Pedraza, and M.T. Kaartinen Osteopontin and wound healing in bone Cells Tissues Organs 194 2011 313 319
3. S.A. Lund, C.M. Giachelli, and M. Scatena The role of osteopontin in inflammatory processes J Cell Commun Signal 3 2009 311 322
4. J.Y. Kim, B.N. Bae, K.S. Kim, E. Shin, and K. Park Osteopontin. CD44, and NFkappaB expression in gastric adenocarcinoma Cancer Res Treat 41 2009 29 35
5. P.Y. Wai, and P.C. Kuo Osteopontin: regulation in tumor metastasis Cancer Metastasis Rev 27 2008 103 118
6. D. Coppola, M. Szabo, D. Boulware, P. Muraca, M. Alsarraj, A.F. Chambers, and T.J. Yeatman Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies Clin Cancer Res 10 2004 184 190
7. D. Agrawal, T. Chen, R. Irby, J. Quackenbush, A.F. Chambers, M. Szabo, A. Cantor, D. Coppola, and T.J. Yeatman Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling J Natl Cancer Inst 94 2002 513 521
8. F. Rohde, C. Rimkus, J. Friederichs, R. Rosenberg, C. Marthen, D. Doll, B. Holzmann, J.R. Siewert, and K.P. Janssen Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer Int J Cancer 121 2007 1717 1723
9. W. Likui, W. Hong, and Z. Shuwen Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer J Gastrointest Surg 14 2010 74 81
10. P.H. Anborgh, J.C. Mutrie, A.B. Tuck, and A.F. Chambers Role of the metastasis-promoting protein osteopontin in the tumour microenvironment J Cell Mol Med 14 2010 2037 2044
11. N.F. Paoni, M.W. Feldman, L.S. Gutierrez, V.A. Ploplis, and F.J. Castellino Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse Physiol Genomics 15 2003 228 235
12. A.F. Chambers, E.I. Behrend, S.M. Wilson, and D.T. Denhardt Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells Anticancer Res 12 1992 43 47
13. S.L. Madden, E.A. Galella, J. Zhu, A.H. Bertelsen, and G.A. Beaudry SAGE transcript profiles for p53-dependent growth regulation Oncogene 15 1997 1079 1085
14. J. Li, G.Z. Yang, Z.M. Zhu, Z.Y. Zhou, and L. Li Osteopontin is overexpressed in colorectal carcinoma and is correlated with P53 by immunohistochemistry Exp Ther Med 3 2012 621 624
15. Y. Takami, M.B. Russell, C. Gao, Z. Mi, H. Guo, C.R. Mantyh, and P.C. Kuo Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells Surgery 142 2007 163 169
16. C. Martinez, M. Churchman, T. Freeman, and M. Ilyas Osteopontin provides early proliferative drive and may be dependent upon aberrant c-myc signalling in murine intestinal tumours Exp Mol Pathol 88 2010 272 277
17. M.K. El-Tanani, F.C. Campbell, P. Crowe, P. Erwin, D.P. Harkin, P. Pharoah, B. Ponder, and P.S. Rudland BRCA1 suppresses osteopontin-mediated breast cancer J Biol Chem 281 2006 26587 26601
18. A. Ravindranath, H.F. Yuen, K.K. Chan, C. Grills, D.A. Fennell, T.R. Lappin, and M. El-Tanani Wnt-beta-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer Br J Cancer 105 2011 542 551
19. Y.N. Liu, B.B. Kang, and J.H. Chen Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells Oncogene 23 2004 278 288
20. R. Zagani, N. Hamzaoui, W. Cacheux, A. de Reynies, B. Terris, S. Chaussade, B. Romagnolo, C. Perret, and D. Lamarque Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers Gastroenterology 137 2009 1358 1366 e1-3
21. M. El-Tanani, A. Platt-Higgins, P.S. Rudland, and F.C. Campbell Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription J Biol Chem 279 2004 20794 20806
22. E. Bonnelye, J.M. Vanacker, N. Spruyt, S. Alric, B. Fournier, X. Desbiens, and V. Laudet Expression of the estrogen-related receptor 1 (ERR-1) orphan receptor during mouse development Mech Dev 65 1997 71 85
23. J.M. Vanacker, C. Delmarre, X. Guo, and V. Laudet Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha Cell Growth Differ 9 1998 1007 1014
24. R.A. Zirngibl, J.S. Chan, and J.E. Aubin Estrogen receptor-related receptor alpha (ERRalpha) regulates osteopontin expression through a non-canonical ERRalpha response element in a cell context-dependent manner J Mol Endocrinol 40 2008 61 73
25. V. Giguere, N. Yang, P. Segui, and R.M. Evans Identification of a new class of steroid hormone receptors Nature 331 1988 91 94
26. S.N. Schreiber, D. Knutti, K. Brogli, T. Uhlmann, and A. Kralli The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha) J Biol Chem 278 2003 9013 9018
27. J. Laganiere, G.B. Tremblay, C.R. Dufour, S. Giroux, F. Rousseau, and V. Giguere A polymorphic autoregulatory hormone response element in the human estrogen-related receptor alpha (ERRalpha) promoter dictates peroxisome proliferator-activated receptor gamma coactivator-1alpha control of ERRalpha expression J Biol Chem 279 2004 18504 18510
28. B.B. Busch, W.C. Stevens Jr., R. Martin, P. Ordentlich, S. Zhou, D.W. Sapp, R.A. Horlick, and R. Mohan Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha J Med Chem 47 2004 5593 5596
29. C.Y. Chang, and D.P. McDonnell Molecular pathways: the metabolic regulator estrogen-related receptor alpha as a therapeutic target in cancer Clin Cancer Res 18 2012 6089 6095
30. V. Giguere Transcriptional control of energy homeostasis by the estrogen-related receptors Endocr Rev 29 2008 677 696
31. E.A. Ariazi, G.M. Clark, and J.E. Mertz Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer Cancer Res 62 2002 6510 6518
32. T. Suzuki, Y. Miki, T. Moriya, N. Shimada, T. Ishida, H. Hirakawa, N. Ohuchi, and H. Sasano Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor Cancer Res 64 2004 4670 4676
33. G. Deblois, G. Chahrour, M.C. Perry, G. Sylvain-Drolet, W.J. Muller, and V. Giguere Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis Cancer Res 70 2010 10277 10287
34. A. Fradet, H. Sorel, L. Bouazza, D. Goehrig, B. Depalle, A. Bellahcene, V. Castronovo, H. Follet, F. Descotes, J.E. Aubin, P. Clezardin, and E. Bonnelye Dual function of ERRalpha in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin Cancer Res 71 2011 5728 5738
35. C.P. Cheung, S. Yu, K.B. Wong, L.W. Chan, F.M. Lai, X. Wang, M. Suetsugi, S. Chen, and F.L. Chan Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues J Clin Endocrinol Metab 90 2005 1830 1844
36. T. Fujimura, S. Takahashi, T. Urano, J. Kumagai, T. Ogushi, K. Horie-Inoue, Y. Ouchi, T. Kitamura, M. Muramatsu, and S. Inoue Increased expression of estrogen-related receptor alpha (ERRalpha) is a negative prognostic predictor in human prostate cancer Int J Cancer 120 2007 2325 2330
37. J. Fujimoto, S.M. Alam, I. Jahan, E. Sato, H. Sakaguchi, and T. Tamaya Clinical implication of estrogen-related receptor (ERR) expression in ovarian cancers J Steroid Biochem Mol Biol 104 2007 301 304
38. M. Gao, P. Sun, J. Wang, D. Zhao, and L. Wei Expression of estrogen receptor-related receptor isoforms and clinical significance in endometrial adenocarcinoma Int J Gynecol Cancer 16 2006 827 833
39. A. Cavallini, M. Notarnicola, R. Giannini, S. Montemurro, D. Lorusso, A. Visconti, F. Minervini, and M.G. Caruso Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen receptors (ERalpha and ERbeta) exhibit different gene expression in human colorectal tumour progression Eur J Cancer 41 2005 1487 1494
40. A. Cavallini, M. Notarnicola, R. Giannini, S. Montemurro, D. Lorusso, A. Visconti, F. Minervini, and M.G. Caruso Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen receptors (ERalpha and ERbeta) exhibit different gene expression in human colorectal tumour progression Eur J Cancer 41 2005 1487 1494
41. S. Bianco, O. Lanvin, V. Tribollet, C. Macari, S. North, and J.M. Vanacker Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation J Biol Chem 284 2009 23286 23292
42. R.A. Stein, C.Y. Chang, D.A. Kazmin, J. Way, T. Schroeder, M. Wergin, M.W. Dewhirst, and D.P. McDonnell Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer Cancer Res 68 2008 8805 8812
43. M.A. Dwyer, J.D. Joseph, H.E. Wade, M.L. Eaton, R.S. Kunder, D. Kazmin, C.Y. Chang, and D.P. McDonnell WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration Cancer Res 70 2010 9298 9308
44. A. Ao, H. Wang, S. Kamarajugadda, and J. Lu Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors Proc Natl Acad Sci U S A 105 2008 7821 7826
45. G. Deblois, J.A. Hall, M.C. Perry, J. Laganiere, M. Ghahremani, M. Park, M. Hallett, and V. Giguere Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity Cancer Res 69 2009 6149 6157
46. N. Chen, and Q. Zhou Constructing tissue microarrays without prefabricating recipient blocks: a novel approach Am J Clin Pathol 124 2005 103 107
47. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 e45
48. J.C. Carrier, G. Deblois, C. Champigny, E. Levy, and V. Giguere Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine J Biol Chem 279 2004 52052 52058
49. J. Sonoda, J. Laganiere, I.R. Mehl, G.D. Barish, L.W. Chong, X. Li, I.E. Scheffler, D.C. Mock, A.R. Bataille, F. Robert, C.H. Lee, V. Giguere, and R.M. Evans Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense Genes Dev 21 2007 1909 1920
50. R.D. Michalek, V.A. Gerriets, A.G. Nichols, M. Inoue, D. Kazmin, C.Y. Chang, M.A. Dwyer, E.R. Nelson, K.N. Pollizzi, O. Ilkayeva, V. Giguere, W.J. Zuercher, J.D. Powell, M.L. Shinohara, D.P. McDonnell, and J.C. Rathmell Estrogen-related receptor-alpha is a metabolic regulator of effector T-cell activation and differentiation Proc Natl Acad Sci U S A 108 2011 18348 18353
51. M. Rossi, D. Colecchia, C. Iavarone, A. Strambi, F. Piccioni, A. Verrotti di Pianella, and M. Chiariello Extracellular signal-regulated kinase 8 (ERK8) controls estrogen-related receptor alpha (ERRalpha) cellular localization and inhibits its transcriptional activity J Biol Chem 286 2011 8507 8522
52. V. Giroux, G. Bernatchez, T. Lassalle, J.-F. Beaulieu, and J. Carrier The metabolic regulator ERRalpha and its splice variant regulate colon carcinogenesis (abstract) Can J Gastroenterol 26 2012 A119
53. R.A. Stein, S. Gaillard, and D.P. McDonnell Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells J Steroid Biochem Mol Biol 114 2009 106 112
54. E. Bonnelye, F. Saltel, A. Chabadel, R.A. Zirngibl, J.E. Aubin, and P. Jurdic Involvement of the orphan nuclear estrogen receptor-related receptor alpha in osteoclast adhesion and transmigration J Mol Endocrinol 45 2010 365 377
55. A.W. Jones, Z. Yao, J.M. Vicencio, A. Karkucinska-Wieckowska, and G. Szabadkai PGC-1 family coactivators and cell fate: roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling Mitochondrion 12 2011 86 99
56. P. Sharma, S. Kumar, and G.C. Kundu Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells Mol Cancer 9 2010 178